GVS
870976
Hangzhou CNCR-IT
300250
Shanghai Newtouch Software
688590
4
Nexwise Intelligence China
301248
5
Astro-century Education & Technology
300654
US Stock MarketDetailed Quotes
UPB UpStream Bio
- 10.770
- 0.0000.00%
Close Jan 23 16:00 ET
- 10.770
- 0.0000.00%
Post 20:01 ET
577.24MMarket Cap-8.30P/E (TTM)
11.150High10.380Low176.90KVolume10.800Open10.770Pre Close1.89MTurnover1.03%Turnover RatioLossP/E (Static)53.60MShares29.46052wk High-3.60P/B185.78MFloat Cap10.36052wk Low--Dividend TTM17.25MShs Float29.460Historical High--Div YieldTTM7.15%Amplitude10.360Historical Low10.708Avg Price1Lot Size
About UpStream Bio Company
Upstream Bio, Inc. is a clinical-stage biotechnology company, which engages in the development of treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. It develops verekitug, the only known antagonist currently in clinical development that targets the receptor for Thymic Stromal Lymphopoietin. The company was founded in April 2021 and is headquartered in Waltham, MA.
Company Profile
SymbolUPB
Company NameUpStream Bio
Listing DateOct 11, 2024
Issue Price17.00
Founded2021
CEODr. Everett Rand Sutherland, M.D.
MarketNASDAQ
Employees41
Fiscal Year Ends12-31
Address890 Winter Street,Suite 200
CityWaltham
ProvinceMassachusetts
CountryUnited States of America
Zip Code02451
Phone1-781-208-2466
Websitehttp://www.upstreambio.com
Company Executives
- Name
- Position
- Salary
- Dr. Everett Rand Sutherland, M.D.
- Chief Executive Officer and Director
- --
- Dr. Adam Houghton, PhD
- Chief Business Officer
- --
- Dr. Aaron Deykin, M.D.
- Chief Medical Officer and Head of Research and Development
- 823.24K
- Michael P. Gray
- Chief Financial and Operating Officer
- --
- Ronald C. Renaud, M.B.A.
- Chairman of the Board
- 208.22K
- Erez Chimovits, M.B.A.,M.Sc.
- Independent Director
- --
- Dr. Marcella Kuhlman Ruddy, M.D.
- Independent Director
- 185.33K
- Dr. Liam Ratcliffe, M.D.,PhD
- Independent Director
- --
- Dr. H. Edward Fleming, M.D.
- Independent Director
- --
- Daniella Beckman
- Independent Director
- --
Trending Stocks
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Stocks & Industries to Watch Under Trump's Second Presidency
Key takeaways Tech stocks underwent substantial growth due to tax cuts and reduced corporate regulations in Trump's first term along with defense and aerospace